CNTA Research and Charts

CNTA - Centessa Pharmaceuticals PLC ADR (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2025-06-30)

Last 13.14	Change ⇑ +0.01 (+0.08%)	Volume 1,137,853
	Open 13.13	High 13.29	Low 12.78

8EMA (Daily) 13.09	40EMA (Daily) 12.94	50EMA (Daily) 13.06	STO (Daily) 68.052	MACD Hist (Daily) 0.182
8EMA (Weekly) 12.893	40EMA (Weekly) 13.79	50EMA (Weekly) 13.59	STO (Weekly) 42.295	MACD Hist (Weekly) -0.078


Company Profile
Centessa Pharmaceuticals PLC is a pharmaceutical company. Its portfolio consists of preclinical to phase 3 uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. Some of its products include Vasopressin V2 Receptor Inhibitor (Lixivaptan), BMP9 Engineered Variant (MGX292), OX2R Agonist (Oral) among others.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.